We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1682 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1657Barrons; Biogen's a Buy Jefferies & Co. sees nearly 20% upside from currmopgcw-11/3/2009
1656CS: Biogen Idec. Inc. (BIIB) NEUTRAL [V] M. Aberman CP: US$ 47.23 TP: US$ 54 CAPmopgcw-10/24/2009
1655citi: Biogen Idec Inc (BIIB) More PML Cases Than Expected – True Rate Still Unclmopgcw-10/23/2009
1654CS: CP: US$ 48.60 TP: US$ CAP: US$ 14b Briefing Docs Raise Questions on Fampridimopgcw-10/9/2009
1653DB: ***FDA approved a branded generic form of Bayers Betaseron, beta-interferon,mopgcw-8/26/2009
1652CS: Biogen Idec. Inc. (BIIB) NEUTRAL [V] M. Aberman CP: US$ 47.10 TP: US$ 54 CAPmopgcw-7/18/2009
1651CS: Biogen Idec. Inc. (BIIB) NEUTRAL [V] M. Aberman CP: US$ 50.07 TP: US$ 54 CAPmopgcw-6/29/2009
1650We're now up to 10 PML cases post-relaunch? I missed the other 3 . . tuck-6/29/2009
1649Mr. CI is in it for himself. Maybe with big pharmas narrowing their business fokenhott-5/14/2009
1648What was the point of the merger in the first place if this is the new goal... (mopgcw-5/14/2009
1647A sixth brain infection case from an ex- U.S. patient who had been on Tysabri fotuck-4/17/2009
1646CS: Biogen Idec. Inc. (BIIB) NEUTRAL [V] M. Aberman CP: US$ 51.49 TP: US$ 54 CAPmopgcw-4/17/2009
1645Works for me, thanks!Patrick Slevin-4/7/2009
1644>>rumors of a competitor to Carl making a play...<< Specifically, Satuck-4/7/2009
1643rumors of a competitor to Carl making a play...mopgcw-4/7/2009
1642To anyone; Any idea why the sudden climb in Price this morning?Patrick Slevin-4/7/2009
1641Biogen Faces Heavier Tysabri Pressure R.W. Baird downgraded the biotech and lowmopgcw-2/6/2009
1640more fun'n'games: Icahn Proposes Four Biogen Directors and Move to Northmopgcw-2/6/2009
1639Biogen Idec put on GS' Conviction Buy List: Cheetuck-1/27/2009
1638A friend of mine questioned the IR about the Anti-lingo mab. IND is planned in 2Germanecki-12/19/2008
1637Thx for posting this, as the target is quite interesting. I have been followingBiotech Jim112/16/2008
1636Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple SGermanecki-12/16/2008
1635:( Biogen Cites New Setback for MS Drug Article By KEITH J. WINSTEIN A German mopgcw-12/15/2008
1634CS: Biogen Idec. Inc. (BIIB) Neutral [V] M. Aberman CP: US$ 47.15 TP: US$ 53 CAPmopgcw-12/12/2008
1633DJ newsflash about Biogen reporting a case of leukoencephalopathy in a Tysabri ptuck-10/29/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):